Cosmetic cross-reference Noindex: medium evidence

575-38-2

CAS 575-38-2

575-38-2 (CAS 575-38-2) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed

Label records

0

SOURCE EMBL-EBI ChEMBL

Bioactivity

0

SOURCE DrugCentral

Adverse signals

0

SOURCE IUPHAR/BPS

PubMed IDs

0

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

575-38-2

CAS Number

575-38-2

UNII

7D42F605CS

InChIKey

ZUVBIBLYOCVYJU-UHFFFAOYSA-N

ChEMBL ID

CHEMBL203378

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is 575-38-2 used for in pharmaceutical contexts?

575-38-2 (CAS 575-38-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for 575-38-2?

No adverse-event association or SIDER side-effect rows are rendered for 575-38-2 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is 575-38-2 also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for 1,7-Naphthalenediol with EU status "prohibited".

What clinical phase is 575-38-2 in?

No phase 1-4 clinical development badge is rendered for 575-38-2 because the matched compound identifier rows do not contain a max-phase value.